IRIS
TARAMASSO, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.626
AS - Asia 1.922
NA - Nord America 1.307
SA - Sud America 152
AF - Africa 40
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.052
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 12.319
US - Stati Uniti d'America 1.222
SG - Singapore 736
CN - Cina 491
VN - Vietnam 394
BD - Bangladesh 114
FR - Francia 110
BR - Brasile 91
HK - Hong Kong 51
CA - Canada 48
FI - Finlandia 48
DE - Germania 43
GB - Regno Unito 27
MX - Messico 25
AR - Argentina 24
JP - Giappone 24
IQ - Iraq 22
NL - Olanda 13
ID - Indonesia 12
IN - India 12
PH - Filippine 11
ZA - Sudafrica 10
EC - Ecuador 9
CL - Cile 8
PK - Pakistan 8
CH - Svizzera 6
CO - Colombia 6
PY - Paraguay 6
SA - Arabia Saudita 6
SE - Svezia 6
UA - Ucraina 6
DZ - Algeria 5
RU - Federazione Russa 5
TN - Tunisia 5
TR - Turchia 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
EG - Egitto 4
ES - Italia 4
ET - Etiopia 4
MA - Marocco 4
PE - Perù 4
PS - Palestinian Territory 4
RO - Romania 4
UZ - Uzbekistan 4
GA - Gabon 3
GR - Grecia 3
IE - Irlanda 3
JO - Giordania 3
KE - Kenya 3
KR - Corea 3
MD - Moldavia 3
NP - Nepal 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
VE - Venezuela 3
AG - Antigua e Barbuda 2
AT - Austria 2
BE - Belgio 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
JM - Giamaica 2
MT - Malta 2
PL - Polonia 2
RS - Serbia 2
SI - Slovenia 2
SV - El Salvador 2
AL - Albania 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
CU - Cuba 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
KG - Kirghizistan 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NG - Nigeria 1
OM - Oman 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TW - Taiwan 1
Totale 16.052
Salva come PNG Salva come JPEG
Città #
Genova 5.419
Genoa 4.375
Rapallo 1.163
Vado Ligure 1.143
Singapore 344
San Jose 334
Ashburn 205
Ho Chi Minh City 114
Hanoi 101
Lauterbourg 99
Beijing 91
Council Bluffs 77
New York 73
Hong Kong 50
Helsinki 45
Bordighera 44
Frankfurt am Main 32
Los Angeles 25
Santa Clara 24
Boardman 20
St Louis 20
Haiphong 19
Tokyo 19
Buffalo 17
Da Nang 15
Mexico City 15
Orem 15
Rome 14
Dallas 12
Milan 12
Tianjin 12
Baghdad 11
Toronto 11
Biên Hòa 10
Chicago 10
Montreal 10
London 8
São Paulo 8
Atlanta 7
Bari 7
Palermo 7
Can Tho 6
Denver 6
Houston 6
Rio de Janeiro 6
Amsterdam 5
Asunción 5
Brooklyn 5
Cardiff 5
City of London 5
Florence 5
Guangzhou 5
Jakarta 5
Johannesburg 5
Ninh Bình 5
Phoenix 5
Quảng Ngãi 5
Santiago 5
Stockholm 5
Zurich 5
Addis Ababa 4
Bắc Ninh 4
Guayaquil 4
Kyiv 4
Philadelphia 4
San Francisco 4
Shanghai 4
Turin 4
Amman 3
Ankara 3
Auburn 3
Bogotá 3
Bắc Giang 3
Calgary 3
Cape Town 3
Changsha 3
Cleveland 3
Dublin 3
Fontana 3
Ha Long 3
Hải Dương 3
Jeddah 3
Lappeenranta 3
Libreville 3
Lima 3
Madrid 3
Marseille 3
Memphis 3
Miano 3
New Orleans 3
Paris 3
Phủ Lý 3
Quận Ba 3
Richmond 3
Sydney 3
Thái Nguyên 3
Tunis 3
Verona 3
Vĩnh Long 3
Alexandria 2
Totale 14.263
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 330
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy 274
CD8+CD28-CD127loCD39+regulatory T-cell expansion: A new possible pathogenic mechanism for HIV infection? 259
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 228
Bloodstream infections in patients living with HIV in the modern cART era 218
Is it still worthwhile to perform quarterly CD4+ T lymphocyte cell counts on HIV-1 infected stable patients? 217
Epidemiological and clinical features of hepatitis delta in HBsAg-positive patients by HIV status. 202
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 196
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 193
Pregnancy and neonatal outcomes among a cohort of HIV-infected women in a large Italian teaching hospital: a 30-year retrospective study 190
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 189
AUMENTO DEGLI INDICI DI CITOLISI EPATICA NEI SOGGETTI CON INFEZIONE DA HIV CHE AVVIANO LA PRIMA LINEA DI TRATTAMENTO ANTIRETROVIRALE: STUDIO OSSERVAZIONALE DI COORTE 179
Pharmacokinetics of Lopinavir Determined with an ELISA Test in Youths with Perinatally Acquired HIV. 178
Bloodstream infections in patients living with HIV infection in the recent cART era: did something change?”. 178
Chemotherapy Mass Campaigns and Migratory Flows: An Unexpected Connection 177
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 177
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 175
Bloodstream infections in critically ill patients with COVID-19 175
Bedaquiline: A new hope for shorter and better anti-tuberculosis regimens 169
Reducing CD4+ lymphocyte cell monitoring in HIV-1 stable patients: a forecast of the cost saving 165
Weight gain: A possible side effect of all antiretrovirals 161
How has the cost of antiretroviral therapy changed over the years? A database analysis in Italy 161
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients 156
Successful recovery of associated interstitial nephritis and focal segmental glomerulosclerosis in patients with HCV and HIV treated with sofosbuvir and daclatasvir and revision of literature 156
How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis 156
Will new antimicrobials overcome resistance among Gram-negatives? 154
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 154
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 149
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 149
Ibalizumab and fostemsavir in the management of heavily pre-treated HIV-infected patients 146
Which patients have greatest need for elvitegravir/cobicistat/ emtricitabine/tenofovirDF-based therapy? 144
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 144
Ligurian Vaccination in HIV Program (LIV in HIV): the experience of Genoa metropolitan area 142
Factors associated with hospital admission for COVID-19 in HIV patients 140
Epidemiology, species distribution, antifungal susceptibility and outcome of nosocomial candidemia in a tertiary care hospital in Italy. 139
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 139
Is it time to re-think the use of etravirine in patients with available genotypic resistance test? 139
Time to change the single-centre approach to management of patients with tuberculosis: a novel network platform with automatic data import and data sharing 138
Pineal Germinoma in a Child with Interferon-γ Receptor 1 Deficiency. Case Report and Literature Review 137
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 137
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 136
Incidence and risk factors for liver enzyme elevation among naive HIV-1-infected patients receiving ART in the ICONA cohort 135
HIV-1 RNA quantification in CRF02_AG HIV-1 infection: too easy to make mistakes 132
Increasing prevalence of genitourinary schistosomiasis in Europe in the Migrant Era: Neglected no more? 132
Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors 131
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 131
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography for Diagnosis and Treatment of Sarcoidosis in an HIV-2-Infected Patient. 129
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 129
Distinct features of immune activation and exhaustion markers in people with perinatally-acquired HIV 126
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 126
Computed tomography assessment of PEEP-induced alveolar recruitment in patients with severe COVID-19 pneumonia 125
Rationale for an association between PD1 checkpoint inhibition and therapeutic vaccination against HIV 124
Will vaccine hesitancy compromise our efforts to face the next SARS-CoV-2 epidemic wave? 122
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 122
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 122
Onychomadesis in a male patient with secondary syphilis 121
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 119
Short Communication: Tenofovir Disoproxil Fumarate/Emtricitabine Fits for All as Appropriate HIV-1 Pre-Exposure Prophylaxis? 119
Patient-reported outcomes and low-level residual HIV-RNA in adolescents perinatally infected with HIV-1 after switching to one-pill fixed-dose regimen. 119
Treatment of hepatitis C virus genotype 4 in the DAA era 118
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/ emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: Different effects in patients with or without baseline hypercholesterolemia 118
Switch from unboosted protease inhibitor to a single-tablet regimen containing rilpivirine improves cholesterol and triglycerides 117
Lipid profile changings after switching from rilpivirine/tenofovir disoproxil fumarate/emtricitabine to rilpivirine/tenofovir alafenamide/emtricitabine: different effects in different patients populations. Results from a large observational study 116
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 115
Missed opportunities to prevent mother-to-child transmission of HIV in Italy 114
Injectable Antiretroviral Drugs: Back to the Future 113
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 112
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study 112
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 112
Bloodstream infections in HIV-infected patients 111
Maintenance of Viral Suppression after Optimization Therapy from Etravirine Plus Raltegravir to Rilpivirine Plus Dolutegravir in HIV-1-Infected Patients 110
Increasing use and accessibility of anti parasitic drugs for migrants with neglected diseases at a time of migratory emergency 108
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 108
Co-infezione HIV/HCV e malattia renale: un binomio “scindibile” 106
Hepatitis C virus direct acting antivirals impact on renal function in the first 4 weeks of treatment 104
Viremia copy-years and risk of estimated glomerular filtration rate reduction in adults living with perinatal HIV infection 102
Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy 102
Barriers to HCV micro-elimination in a cohort of people living with HIV (PLWH) 101
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 101
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 101
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 101
HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients 101
Therapeutic management of chronic hepatitis B in clinical Practice: a region-wide survey. 100
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy 99
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 98
Aspetti medico sanitari, area infettivologica. In: Being Positive Strategie e Linguaggi per la comunicazione dell'HIV 97
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination 97
Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study 97
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 95
Monkeypox outbreak in Genoa, Italy: Clinical, laboratory, histopathologic features, management, and outcome of the infected patients 94
CD4+ T lymphocyte recovery in the modern antiretroviral therapy era: Toward a new threshold for defining immunological non-responders 94
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression 92
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19 92
Nasal monkeypox virus infection successfully treated with cidofovir in a patient newly diagnosed with HIV 92
Duration of isolation and precautions in immunocompromised patients with COVID-19 91
HCV elimination plan leads to significant benefits in managing liver-related diseases and hospital interventions: a regional simulation 89
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 89
Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: The HIVand Hypertension Study 88
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge 87
Hypertensive versus HIV-infected patients: Who has the greatest target organ damage? Comparison of carotid plaque prevalence, intima media thickness and renal resistive index in the two groups of patients 85
Totale 13.589
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.881
article - articoli 57.850
book - libri 0
conference - conferenze 1.261
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 307
Totale 119.299
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021152 0 0 0 0 0 0 0 0 0 0 0 152
2021/20221.201 48 39 59 138 51 98 57 270 105 126 50 160
2022/20231.434 119 115 11 130 175 195 64 105 209 109 178 24
2023/2024922 39 94 13 111 68 146 71 64 43 25 98 150
2024/20252.972 91 200 91 188 377 282 353 521 120 149 280 320
2025/20265.444 613 168 464 386 660 379 801 275 453 624 460 161
Totale 16.450